Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
W.C. Mentzer, B.H. Lubin.
Red cell membrane abnormalities.
Pediatric Hematology, 2nd ed, pp. 257-284
[2.]
J. Delaunay.
Hereditary hemolytic anemias due to defects in membrane proteins.
Curr Opin Hematol, 2 (1993), pp. 59-65
[3.]
S.E. Lux, J. Palek.
Disorders of the red cell membrane.
Blood: Principles and Practice in Hematology, pp. 1701-1818
[4.]
A. Iolascon, E. Miraglia del Giudice, S. Perrotta, N. Alloisio, L. Morle, J. Deulaney.
Hereditary spherocytosis: from clinical to molecular defects.
Haematologica, 83 (1998), pp. 240-257
[5.]
L. Pinto, A. Iolascon, E. Miraglia del Giudice, S.M.R. Matarese, B. Nobili, S. Perrotta.
The Italian pediatric survey on hereditary spherocytosis.
Int J Pediatr Hematol Oncol, 2 (1995), pp. 43-44
[6.]
F. Delhommeau, T. Cynober, P.O. Schismanoff, P. Rohrlich, J. Delaunay, N. Mohandas, et al.
Natural history of hereditary spherocytosis during the first year of life.
Blood, 95 (2000), pp. 393-397
[7.]
D.M. Layton, A.J. Bellingham.
Disorders of erythrocyte metabolism.
Pediatric Hematology, 2nd ed, pp. 285-305
[8.]
W.C. Mentzer.
Piruvate kinase deficiency and disorders of glycolysis.
Hematology of Infancy and Childhood, 5th ed, pp. 665-703
[10.]
L. .Luzzato.
Glucosa-6-phosphate dehydrogenase deficiency and hemolytic anemia.
Hematology of Infancy and Childhood, 5th ed, pp. 704-726
[11.]
A.E. Kulozik.
Hemoglobin variants and the rarer hemoglobin disorders.
Pediatric Hematology, 2nd ed, pp. 231-256
[12.]
A. Villegas, P. Ropero.
Talasemias.
Hematologia, pp. 235-247
[13.]
N. Olivieri, D.J. Weatherall.
Thalassemias.
Pediatric Hematology, 2nd ed, pp. 307-327
[14.]
N.F. Olivieri.
The β-Talassemias.
N Engl J Med, 341 (1999), pp. 99-109
[15.]
N.F. Olivieri, G.M. Brittenham.
Iron-chelating therapy and the treatment of Thalassemia.
Blood, 89 (1997), pp. 739-761
[16.]
A.R. Cohen, R. Galanello, A. Piga, A. Di Palma, C. Vullo, F. Tricta.
Safety profile of the oral iron chelator deferiprone: A multicentre study.
Br J Haematol, 108 (2000), pp. 305-312
[17.]
A.J. Bellingham, D.S. Gillett.
Haemoglobinopathies.
Clinical Haematology, pp. 63-76
[18.]
G.R. Serjeant.
Sickle cell disease.
Pediatric Hematology, 2nd ed, pp. 219-230
[19.]
C. Hoppe, L. Styles, E. Vichinsky.
The natural history of sickle cell disease.
Curr Opin Pediatr, 10 (1998), pp. 49-52
[20.]
M.H. Steinberg.
Management of sickle cell disease.
N Engl J Med, 340 (1999), pp. 1021-1029
[21.]
J.J. Ortega.
Anemia de celulas falciformes: una enfermedad emergente en Espana.
An Pediatr, 58 (2003), pp. 93-94
[22.]
M. Maier-redelsperger, D. Labie, J. Elion.
Long-term hydroxiurea treatment in young sickle cell patients.
Curr Opin Hematol, 6 (1999), pp. 115-120
[23.]
A. Ferster, P. Tahriri, C. Vermylen, G. Sturbois, F. Corazza, P. Fondu, et al.
Five years of experience with hydroxyurea in children and young adults.
Blood, 97 (2001), pp. 3628-3632
[24.]
M.C. Walters, M. Patience, W. Leisenring, J.R. Eckman, J.P. Scott, W.C. Mentzer, et al.
Bone Marrow Transplantation for sickle cell disease.
N Engl J Med, 335 (1996), pp. 369-376
[25.]
P. Woodard, M. Jeng, R. Handgretinger, W. Wang, J. Cunningham.
The future of stem cell transplantation for sickle cell disease. Summary of Symposium.
J Pediatr Hematol Oncol, 24 (2002), pp. 512-514
[26.]
E. Dulin, M.A. Cantalejo, M.E. Cela, P. Galaron.
Deteccion precoz neonatal de anemia falciforme y otras hemoglobinopatias en la Comunidad Autonoma de Madrid.
An Pediatr, 58 (2003), pp. 146-155
[27.]
M.V. Sapp, J.B. Bussel.
Immune hemolytic anemias.
Pediatric Hematology, 2nd ed, pp. 203-218
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados